A common genetic variant predicted poor outcomes from peritoneal dialysis, suggesting a potential factor for patient selection and treatment, researchers found. Variants in AQP1, the gene that encodes ...

Among patients starting treatment with peritoneal dialysis, there is broad variability in ultrafiltration, which influences dialysis prescriptions and outcomes. Causes of ultrafiltration variability ...

The diagnosis of systemic arterial hypertension (SAH) in hemodialysis (HD) patients remains controversial. 1,2 Although it is known that continuous ambulatory monitoring of blood pressure (BP) is a ...

For the millions of people living with end‑stage kidney disease, hemodialysis is more than a medical procedure, it is a thrice‑weekly lifeline that keeps the body’s chemistry in balance. Yet even with ...